Impact of Exercise Training Intensity on Abdominal Visceral Fat and Risk Factors Associated With the Metabolic Syndrome
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Virginia
-
Charlottesville, Virginia, United States, 22904
- University of Virginia General Clinical Research Center
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Volunteers must have meet the definition of the metabolic syndrome (based on IDF consensus statement).
- Screening biochemical tests of liver, kidney, hematologic, metabolic (below) and thyroid function must be normal.
The volunteer must be willing to:
- visit the outpatient GCRC or clinic once monthly for 16 weeks of intervention,
- participate in supervised exercise training (if assigned) and
- enter the inpatient GCRC for 2-3 days of more intensive studies at baseline and after 16 weeks of intervention. The subject must provide voluntary and fully informed written consent.
Exclusion Criteria:
- Type 1 diabetes,
- drug or alcohol abuse,
- psychosis,
- severe or untreated depression,
- dementia, polycythemia (hematocrit > 55%),
- clinically symptomatic coronary artery,
- pulmonary or orthopedic disease (which would disallow exercise training),
- history of vascular or peripheral nerve trauma,
- lymph node dissection,
- anemia, uncontrolled hypertension (> 160/105 untreated or > 145/95 treated),
- allergic to octafluoropropane, or nitroglycerine,
- weight loss or gain of 2 kg or more within the preceding 10 days,
- investigational drug use within five biological half-lives,
- treatment with ACE inhibitors or ARBs, thiazolindiones,
- 1st or 2nd generation anti-psychotics insulin, or Viagra,
- unwillingness to provide written informed voluntary consent,
- pregnant, breast feeding or use hormonal birth control.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in Abdominal Visceral Fat
Time Frame: before and after 16 weeks
|
before and after 16 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
VO2peak
Time Frame: before and after 16 weeks
|
before and after 16 weeks
|
|
% Body Fat
Time Frame: before and after 16 weeks
|
before and after 16 weeks
|
|
Insulin
Time Frame: before and after 16 weeks
|
before and after 16 weeks
|
|
FFA
Time Frame: before and after 16 weeks
|
before and after 16 weeks
|
|
Glucose
Time Frame: before and after 16 weeks
|
before and after 16 weeks
|
|
Hba1c
Time Frame: before and after 16 weeks
|
before and after 16 weeks
|
|
Cholesterol
Time Frame: before and after 16 weeks
|
before and after 16 weeks
|
|
CRP
Time Frame: before and after 16 weeks
|
before and after 16 weeks
|
|
IL6
Time Frame: before and after 16 weeks
|
before and after 16 weeks
|
|
TNF
Time Frame: before and after 16 weeks
|
before and after 16 weeks
|
|
Homocysteine
Time Frame: before and after 16 weeks
|
before and after 16 weeks
|
|
Adiponectin
Time Frame: before and after 16 weeks
|
before and after 16 weeks
|
|
Adhesion Molecules
Time Frame: before and after 16 weeks
|
before and after 16 weeks
|
|
Endothelial Function
Time Frame: before and after 16 weeks
|
before and after 16 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Arthur Weltman, PhD, University of Virginia
- Study Director: Brian A Irving, PhD, University of Virginia
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- UVAHIC11145
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.